MorphoSys AG - stock earnings
MOR Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 53.4 million USD | 65.3 million USD |
| 2023Q3 | -126.6 million USD | 67.5 million USD |
| 2023Q2 | -80.4 million USD | 57.8 million USD |
| 2023Q1 | -47.8 million USD | 67.9 million USD |
| 2022Q4 | 353.5 million USD | 87.6 million USD |
| 2022Q3 | -120.5 million USD | 93.9 million USD |
| 2022Q2 | -245.7 million USD | 62.2 million USD |
| 2022Q1 | -206.8 million USD | 46.3 million USD |
| 2021Q4 | -433.3 million USD | 60.2 million USD |
| 2021Q3 | -130.6 million USD | 47.8 million USD |
| 2021Q2 | 24.8 million USD | 45.3 million USD |
| 2021Q1 | -47.6 million USD | 55.3 million USD |
| 2020Q4 | -20.1 million USD | 43.9 million USD |
| 2020Q3 | -76.7 million USD | 25.8 million USD |
| 2020Q2 | -59.6 million USD | 20.7 million USD |
| 2020Q1 | 215.7 million USD | 277.1 million USD |
| 2019Q4 | -56.4 million USD | 12.4 million USD |
| 2019Q3 | -26.4 million USD | 13.6 million USD |
| 2019Q2 | -6.7 million USD | 39.4 million USD |
| 2019Q1 | -25.5 million USD | 15.2 million USD |
| 2018Q4 | -49.6 million USD | 12.0 million USD |
| 2018Q3 | 35.2 million USD | 64.0 million USD |
| 2018Q2 | -27.2 million USD | 9.4 million USD |
| 2018Q1 | -24.0 million USD | 3.4 million USD |
| 2017Q4 | -17.5 million USD | 33.6 million USD |
| 2017Q3 | -28.3 million USD | 17.7 million USD |
| 2017Q2 | -18.4 million USD | 13.4 million USD |
| 2017Q1 | -16.1 million USD | 12.7 million USD |
| 2016Q4 | -30.2 million USD | 13.7 million USD |
| 2016Q3 | -14.4 million USD | 14.0 million USD |
| 2016Q2 | -12.9 million USD | 13.5 million USD |
| 2016Q1 | -8.2 million USD | 13.7 million USD |
| 2015Q4 | -14.6 million USD | 13.5 million USD |
| 2015Q3 | -9.3 million USD | 12.7 million USD |
| 2015Q2 | -4.9 million USD | 13.7 million USD |
| 2015Q1 | 44.2 million USD | 76.3 million USD |
| 2014Q4 | -1.2 million USD | 20.7 million USD |
| 2014Q3 | -3.3 million USD | 20.8 million USD |
| 2014Q2 | -718692 USD | 20.0 million USD |
| 2014Q1 | 1.5 million USD | 21.8 million USD |
| 2013Q4 | -4.9 million USD | 19.8 million USD |
| 2013Q3 | -2.8 million USD | 20.7 million USD |
| 2013Q2 | 14.5 million USD | 40.8 million USD |
| 2013Q1 | 10.1 million USD | 21.7 million USD |
| 2012Q4 | 4.2 million USD | 4.0 million USD |
| 2012Q3 | -320852 USD | 20.5 million USD |
| 2012Q2 | -558237 USD | 21.0 million USD |
| 2012Q1 | -699513 USD | 21.5 million USD |
| 2011Q4 | -6.2 million USD | 22.1 million USD |
| 2011Q3 | -2.7 million USD | 23.2 million USD |
| 2011Q2 | -5.5 million USD | 26.1 million USD |
| 2011Q1 | 26.6 million USD | 68.6 million USD |
| 2010Q4 | 2.6 million USD | 32.3 million USD |
| 2010Q3 | 1.8 million USD | 26.3 million USD |
| 2010Q2 | 3.3 million USD | 28.0 million USD |
| 2010Q1 | 4.3 million USD | 27.8 million USD |
| 2009Q4 | 1.9 million USD | 33.6 million USD |
| 2009Q3 | 3.8 million USD | 28.9 million USD |
| 2009Q2 | 2.2 million USD | 26.3 million USD |
| 2009Q1 | 4.6 million USD | 25.3 million USD |
MOR Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -209.7 million USD | 263.4 million USD |
| 2022 | -162.1 million USD | 298.6 million USD |
| 2021 | -585.1 million USD | 204.3 million USD |
| 2020 | 119.2 million USD | 399.1 million USD |
| 2019 | -115.4 million USD | 80.4 million USD |
| 2018 | -64.3 million USD | 87.5 million USD |
| 2017 | -83.4 million USD | 79.8 million USD |
| 2016 | -63.5 million USD | 52.3 million USD |
| 2015 | 16.3 million USD | 116.1 million USD |
| 2014 | -3.7 million USD | 77.8 million USD |
| 2013 | 18.4 million USD | 107.7 million USD |
| 2012 | 2.6 million USD | 68.5 million USD |
| 2011 | 10.6 million USD | 130.6 million USD |
| 2010 | 12.2 million USD | 115.8 million USD |
| 2009 | 12.8 million USD | 116.1 million USD |
| 2008 | 18.3 million USD | 99.8 million USD |
| 2007 | 16.8 million USD | 90.5 million USD |
| 2006 | 8.0 million USD | 70.0 million USD |
| 2005 | 5.5 million USD | 9.4 million USD |
| 2004 | 382530 USD | 29.8 million USD |
| 2003 | -5.2 million USD | 19.3 million USD |
| 2002 | -25.6 million USD | 17.6 million USD |
MOR
Price: $17.89
52 week price:
Payout Ratio Range:
Earnings Per Share: -1.50 USD
P/E Ratio: 23.99
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 71900
Market Capitalization: 2.7 billion